COntrolled MyeloFibrosis Study with ORal JAK Inhibitor Treatment-II (The COMFORT-II Trial)
Laufzeit: 01.01.2009 - 31.12.2013
imported
Kurzfassung
A randomized study of the JAK inhibitor INCB018424 tablets compared to best available therapy in subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF)
